MEE WAI LAM
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family EUGENE, OR NPI 1275960916
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family OR Amgen Inc. All categories
General Payments — all program years on this page
$159.91
- Category: General Payments
- Program years: PY2021
- Record count: 10
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $159.91 across 10 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $159.91 | 10 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $58.04 | 3 |
| Lilly USA, LLC | $43.37 | 3 |
| ABBVIE INC. | $29.70 | 2 |
| Novo Nordisk AS | $28.80 | 2 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2021 | $159.91 | 10 |
Records — PY2021 (10)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 794727385 | AbbVie Inc. | $14.54 | 02/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 794727389 | AbbVie Inc. | $15.16 | 11/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 810792885 | Novo Nordisk Inc | $12.67 | 02/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 810792889 | Novo Nordisk Inc | $16.13 | 08/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 819313497 | Lilly USA, LLC | $14.60 | 08/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 819317327 | Lilly USA, LLC | $12.37 | 06/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 819366365 | Lilly USA, LLC | $16.40 | 02/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 826160379 | Amgen Inc. | $17.26 | 03/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 826160383 | Amgen Inc. | $21.71 | 01/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 826160387 | Amgen Inc. | $19.07 | 04/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.